★ WIDE MOAT STOCKS COMPARISON ★
VOL. XCIV, NO. 247
Stock Comparison
Abbott Laboratories vs Johnson & Johnson
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Abbott Laboratories
ABT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisJohnson & Johnson
JNJ · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.
View JNJ analysisComparison highlights
- Moat score gap: Johnson & Johnson leads (73 / 100 vs 22 / 100 for Abbott Laboratories).
- Segment focus: Abbott Laboratories has 9 segments (27% in Cardiovascular and Electrophysiology Devices); Johnson & Johnson has 2 segments (64.7% in Innovative Medicine).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Abbott Laboratories has 1 moat types across 1 domains; Johnson & Johnson has 3 across 2.
Primary market context
Abbott Laboratories
Cardiovascular and Electrophysiology Devices
Rhythm management, electrophysiology, heart failure, vascular and structural-heart devices
Global
Hospitals, ambulatory surgery centers and cardiovascular clinicians
Implantable and procedure-based device manufacturer
27%
Johnson & Johnson
Innovative Medicine
Branded prescription pharmaceuticals (biopharma)
Global
Wholesalers, hospitals, retailers, healthcare professionals, payers
Drug discovery, development, manufacturing, commercialization
64.7%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Abbott Laboratories strengths
Johnson & Johnson strengths
Segment mix
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Core Laboratory Diagnostics
Oligopoly
Rapid and Molecular Diagnostics
Competitive
Cancer Diagnostics
Competitive
Diabetes Care (CGM and glucose monitoring)
Oligopoly
Cardiovascular and Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
Johnson & Johnson segments
Full profile >Innovative Medicine
Competitive
MedTech
Oligopoly
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.